Cavernous and systemic testosterone plasma levels during different penile conditions in healthy males and patients with erectile dysfunction.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 11549495)

Published in Urology on September 01, 2001

Authors

A J Becker1, S Uckert, C G Stief, F Scheller, W H Knapp, U Hartmann, U Jonas

Author Affiliations

1: Department of Urology, Hannover Medical School, Hannover, Germany.

Articles by these authors

Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol (2007) 3.61

Knock-out mutants from an En-1 mutagenized Arabidopsis thaliana population generate phenylpropanoid biosynthesis phenotypes. Proc Natl Acad Sci U S A (1998) 2.68

Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol (2004) 2.07

Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer (1986) 1.95

Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology (2001) 1.92

Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. Eur Urol (2002) 1.91

Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol (1999) 1.88

Impaired migration but not differentiation of haematopoietic stem cells in the absence of beta1 integrins. Nature (1996) 1.87

Dopamine transporter binding in Gilles de la Tourette syndrome. J Neurol (2000) 1.79

[1-(11)C]Acetate as a quantitative perfusion tracer in myocardial PET. J Nucl Med (2001) 1.78

Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging (2004) 1.71

Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology (2000) 1.61

The neural cell adhesion molecule is a receptor for rabies virus. J Virol (1998) 1.60

Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology (2000) 1.50

Cardiovascular and endocrine alterations after masturbation-induced orgasm in women. Psychosom Med (1999) 1.50

The "music" of core-shell spheres and hollow capsules: influence of the architecture on the mechanical properties at the nanoscale. Nano Lett (2008) 1.49

Single potential analysis of cavernous electrical activity in spinal cord injury patients. J Urol (1994) 1.43

Uncircumcision: a historical review of preputial restoration. Plast Reconstr Surg (1998) 1.43

Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol (2009) 1.43

Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol (2001) 1.41

Determination of brain death with technetium-99m-HMPAO. J Nucl Med (1990) 1.38

The portrait of James Israel by the German impressionist Max Liebermann: a selected pictorial view on the early twentieth century development of surgical urology in Berlin. World J Urol (2001) 1.37

68Ga-labelled DOTA-derivatised peptide ligands. Eur J Nucl Med Mol Imaging (2004) 1.34

Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest (1992) 1.28

Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA. J Biol Chem (1990) 1.26

Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol Scand (1991) 1.24

Regulation of the mammalian pyruvate dehydrogenase complex by covalent modification. Symp Soc Exp Biol (1973) 1.24

Neurospora crassa pyruvate dehydrogenase: interconversion by phosphorylation and dephosphorylation. FEBS Lett (1972) 1.22

Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections. Am J Pathol (2000) 1.18

Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Diabetes (1997) 1.17

Recovery correction for quantitation in emission tomography: a feasibility study. Eur J Nucl Med (2000) 1.16

Activation of human peripheral monocytes by angiotensin II. FEBS Lett (1994) 1.16

Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients. Eur J Nucl Med Mol Imaging (2003) 1.12

Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol (1996) 1.11

Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets (2005) 1.11

Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter? World J Urol (2007) 1.11

Outcome after radioiodine therapy in 107 patients with differentiated thyroid carcinoma and initial bone metastases: side-effects and influence of age. Eur J Nucl Med (2001) 1.10

Air cystoscopy: the history of an endoscopic technique from the late 19th century. BJU Int (1999) 1.09

Curiosity in urology? Masturbation injuries. Eur Urol (1980) 1.09

Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol (2001) 1.06

Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol (1986) 1.03

Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder. Eur Urol (2002) 1.03

Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring. Eur J Radiol (2007) 1.03

Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord (2001) 1.02

Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer (2001) 1.02

Neuroendocrine response to film-induced sexual arousal in men and women. Psychoneuroendocrinology (2000) 1.01

Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res (1999) 1.00

Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence. Int Urol Nephrol (1991) 1.00

Changes in myelin sheath thickness and internode geometry in the rabbit phrenic nerve during growth. J Anat (1985) 1.00

[Diagnosis and treatment of colorectal liver metastases - workflow]. Zentralbl Chir (2008) 0.98

Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol (1994) 0.98

Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation. Eur J Med Res (2010) 0.97

Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside. World J Urol (2001) 0.97

Silicone-silver penile prosthesis: description, operative approach and results. J Urol (1980) 0.97

T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology (1996) 0.97

The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int (2002) 0.97

[Genital self-injury behavior--phenomenologic and differential diagnosis considerations from the psychiatric viewpoint]. Fortschr Neurol Psychiatr (1997) 0.97

A population survey of sexual activity, sexual dysfunction and associated help-seeking behavior in middle-aged and older adults in Germany. Eur J Med Res (2005) 0.96

Attenuation correction by simultaneous emission-transmission myocardial single-photon emission tomography using a technetium-99m-labelled radiotracer: impact on diagnostic accuracy. Eur J Nucl Med (1997) 0.96

The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. Eur Urol (2005) 0.96

Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group. Diabetologia (2000) 0.96

Surgery for metachronous solitary liver metastases of renal cell carcinoma. J Urol (1997) 0.95

Orchitis following mumps vaccination in an adult. Urol Int (1994) 0.95

Perioperative search for circulating tumor cells in patients undergoing radical cystectomy for bladder cancer. Eur J Med Res (2009) 0.95

Influence of rhTSH on [(18)F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging (2002) 0.95

Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. Eur J Nucl Med Mol Imaging (2002) 0.95

Familial papillary thyroid carcinoma: genetics, criteria for diagnosis, clinical features, and surgical treatment. World J Surg (2000) 0.94

Efficacy of retrograde ureteropyeloscopic holmium laser lithotripsy for intrarenal calculi >2 cm. Urol Res (2010) 0.94

The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study. J Urol (1995) 0.94

Determination of nitric oxide metabolites by means of the Griess assay and gas chromatography-mass spectrometry in the cavernous and systemic blood of healthy males and patients with erectile dysfunction during different functional conditions of the penis. Urol Res (2000) 0.94

Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol (2003) 0.94

Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res (1996) 0.94

CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer. Oncogene (2006) 0.93

Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res (2000) 0.93

Research and development of biosensors. A review. Analyst (1989) 0.93

Tamsulosin, the first prostate-selective alpha 1A-adrenoceptor antagonist. Analysis of a multinational, multicentre, open-label study assessing the long-term efficacy and safety in patients with benign prostatic obstruction (symptomatic BPH). European Tamsulosin Study Group. Eur Urol (1996) 0.92

Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder. World J Urol (2000) 0.92

Increased expression of nestin in the major pelvic ganglion following cavernous nerve injury. Int J Impot Res (2011) 0.92

Transurethral microwave thermotherapy for the treatment of BPH: still a challenger? World J Urol (2006) 0.91

Current trends in corpus cavernosum EMG. Conclusions of the 'First International Workshop on Smooth Muscle EMG Recordings/Leiomyogram' April 15 to 17, 1993 in Mannheim, Germany. Int J Impot Res (1993) 0.91

Penile detumescence: characterization of three phases. J Urol (1991) 0.91

Selective drug-induced reduction of blood flow in tumor transplants. Int J Radiat Oncol Biol Phys (1985) 0.91

Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J Endocrinol (2003) 0.91

Positive correlation between reduction of handwriting area and D2 dopamine receptor occupancy during treatment with neuroleptic drugs. Psychiatry Res (1999) 0.91